| 06/08/2026 3:38 PM | Neuronetics (1227636) Subject Sullivan Keith J (1417973) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/29/2026 4:28 PM | Neuronetics (1227636) Filer | Form SD Specialized Disclosure Report | |
| 05/29/2026 4:10 PM | Neuronetics (1227636) Issuer Rosengarten Megan (1876577) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 3:59 PM | Amin Avinash (2044406) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:01 PM | CASCELLA ROBERT (1218713) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:02 PM | CONLEY SHERYL L (1238659) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:04 PM | Cucuz Sasha (2004858) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:05 PM | MUIR GLENN P (1181190) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 3:45 PM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/27/2026 9:33 AM | Chernett Jorey (2042077) Filed by Neuronetics (1227636) Subject | Form SCHEDULE 13D/A | |
| 05/22/2026 6:30 AM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for STIM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Neuronetics and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/21/2026 3:05 PM | Neuronetics (1227636) Issuer Pfanstiel Steven (1856059) Reporting | Form 4/A | |
| 05/20/2026 11:39 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 7:31 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 8:10 AM | Neuronetics (1227636) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/05/2026 7:04 AM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/22/2026 8:39 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/12/2026 11:15 PM | Neuronetics (1227636) Filer | Form EFFECT | |
| 04/09/2026 3:02 PM | Neuronetics (1227636) Filer | Form DEF 14A | |
| 04/09/2026 3:05 PM | Neuronetics (1227636) Filer | Form DEFA14A | |
| 04/08/2026 8:17 AM | Chernett Jorey (2042077) Filed by Neuronetics (1227636) Subject | Form SCHEDULE 13D/A | |
| 04/06/2026 3:40 PM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/01/2026 3:57 PM | Madryn Asset Management, LP (1787423) Reporting MADRYN HEALTH ADVISORS GP II, LLC (2007801) Reporting MADRYN HEALTH ADVISORS II, LP (2007977) Reporting MADRYN HEALTH PARTNERS II (0) CAYMAN MASTER Madryn Health Partners II, LP (1919858) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/30/2026 6:41 PM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/30/2026 8:37 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 8:33 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 4:52 PM | Neuronetics (1227636) Issuer Pfanstiel Steven (1856059) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 4:48 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 4:50 PM | Neuronetics (1227636) Issuer Sullivan Keith J (1417973) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 3:38 PM | Neuronetics (1227636) Issuer REUVERS DANIEL L. (1563602) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/23/2026 3:41 PM | Neuronetics (1227636) Issuer REUVERS DANIEL L. (1563602) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 8:34 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 7:51 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/19/2026 3:36 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/18/2026 9:36 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 9:31 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 8:20 AM | Chernett Jorey (2042077) Filed by Neuronetics (1227636) Subject | Form SCHEDULE 13G/A | |
| 03/17/2026 12:09 PM | Neuronetics (1227636) Subject Parian Ultreia LP (2075833) Filed by | Form SCHEDULE 13G | |
| 03/17/2026 6:55 AM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/17/2026 7:00 AM | Neuronetics (1227636) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/06/2026 3:29 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Why this tiny stock may move before the SpaceX IPO drops (Ad) The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillion in stored capital will be looking for a home when it does.
But the real opportunity isn't the IPO itself. Jovine has identified a small-cap supplier trading near $4 that sits directly in the path of xAI's Colossus infrastructure buildout - and a specific trigger in the S-1 could reprice it overnight. Get the ticker and full briefing before the June roadshow begins |
| 03/04/2026 4:33 PM | Madryn Asset Management, LP (1787423) Filed by Neuronetics (1227636) Subject | Form SCHEDULE 13D/A | |
| 03/04/2026 2:09 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 3:30 PM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/26/2026 2:16 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/26/2026 2:33 PM | Neuronetics (1227636) Subject Sullivan Keith J (1417973) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/25/2026 3:45 PM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/25/2026 3:30 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/25/2026 3:30 PM | Neuronetics (1227636) Issuer Pfanstiel Steven (1856059) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/18/2026 4:42 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/18/2026 4:44 PM | Neuronetics (1227636) Issuer Sullivan Keith J (1417973) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/12/2026 2:12 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/12/2026 2:19 PM | Neuronetics (1227636) Subject Sullivan Keith J (1417973) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/10/2026 3:14 PM | Neuronetics (1227636) Subject Sullivan Keith J (1417973) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/04/2026 1:29 PM | Chernett Jorey (2042077) Filed by Neuronetics (1227636) Subject | Form SCHEDULE 13G/A | |
| 01/22/2026 6:30 AM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/06/2026 4:00 PM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/31/2025 4:05 PM | Neuronetics (1227636) Issuer Pfanstiel Steven (1856059) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/31/2025 4:05 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 1:31 PM | Chernett Jorey (2042077) Filed by Neuronetics (1227636) Subject | Form SCHEDULE 13G | |
| 11/04/2025 6:31 AM | Neuronetics (1227636) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/04/2025 6:10 AM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/22/2025 3:45 PM | Cucuz Sasha (2004858) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 3:45 PM | MUIR GLENN P (1181190) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 3:45 PM | CONLEY SHERYL L (1238659) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 3:45 PM | CASCELLA ROBERT (1218713) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/12/2025 3:15 PM | Madryn Asset Management, LP (1787423) Filed by Neuronetics (1227636) Subject | Form SCHEDULE 13D/A | |
| 08/12/2025 3:15 PM | Madryn Asset Management, LP (1787423) Reporting MADRYN HEALTH ADVISORS GP II, LLC (2007801) Reporting MADRYN HEALTH ADVISORS II, LP (2007977) Reporting MADRYN HEALTH PARTNERS II (0) CAYMAN MASTER Madryn Health Partners II, LP (1919858) Reporting MADRYN SELECT ADVISORS GP, LLC (2007745) Reporting MADRYN SELECT ADVISORS, LP (2007794) Reporting Madryn Select Opportunities, LP (1889283) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/08/2025 3:54 PM | Madryn Select Opportunities, LP (1889283) Reporting Neuronetics (1227636) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/07/2025 3:52 PM | Furlong Stephen (1783360) Reporting Neuronetics (1227636) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/06/2025 3:30 PM | Neuronetics (1227636) Filer | Form 424B5 | |
| 08/05/2025 6:31 AM | Neuronetics (1227636) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/05/2025 6:10 AM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/20/2025 11:15 PM | Neuronetics (1227636) Filer | Form EFFECT | |
| 07/15/2025 4:00 PM | Neuronetics (1227636) Issuer Pfanstiel Steven (1856059) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/15/2025 4:00 PM | Neuronetics (1227636) Issuer Pfanstiel Steven (1856059) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 07/15/2025 6:30 AM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/03/2025 4:05 PM | Neuronetics (1227636) Filer | Form S-3 Registration statement under Securities Act of 1933 | |